Suppr超能文献

急性心肌梗死静脉溶栓或直接经皮冠状动脉腔内血管成形术后早期肌红蛋白和MM肌酸激酶同工酶的释放模式及其对再灌注早期无创诊断的意义

Patterns of myoglobin and MM creatine kinase isoforms release early after intravenous thrombolysis or direct percutaneous transluminal coronary angioplasty for acute myocardial infarction, and implications for the early noninvasive diagnosis of reperfusion.

作者信息

Laperche T, Steg P G, Benessiano J, Dehoux M, Juliard J M, Himbert D, Gourgon R

机构信息

Service de Cardiologie, Hôpital Bichat, Paris, France.

出版信息

Am J Cardiol. 1992 Nov 1;70(13):1129-34. doi: 10.1016/0002-9149(92)90042-w.

Abstract

Early noninvasive detection of reperfusion after thrombolysis for acute myocardial infarction may enable detection of unsuccessful thrombolysis in time for rescue percutaneous transluminal coronary angioplasty (PTCA). It has been suggested that repeated measurement of myoglobin or of MM creatine kinase (CK) isoforms enables early detection of reperfusion. Twenty consecutive patients with acute myocardial infarction treated by intravenous thrombolysis underwent serial determination of myoglobin, MM3 and MM1 CK isoforms every 30 minutes after the beginning of thrombolysis. At 90 minutes, coronary angiography was performed, enabling classification of patients as with (group A) and without (group B) reperfusion. A third group of 7 patients (group C) underwent direct PTCA without antecedent thrombolysis. In all groups, there were increases in myoglobin, percentage of MM3 isoform, and ratio of MM3/MM1. These increases appeared on the average steeper and faster in group B, but the large dispersion of values in this group resulted in a wide overlap with group A. Retrospective analysis suggests that an increase in the MM3/MM1 ratio > 0.35 after 60 minutes is very specific for reperfusion (sensitivity 60% and specificity 100%). In group C, PTCA always led to a sharp increase in all biochemical parameters measured within 30 minutes. Thus, macromolecular markers can be used for very early, noninvasive detection of reperfusion with a high specificity. This could help reduce the need for emergency angiography to select candidates for rescue PTCA. Furthermore, the patterns of biochemical markers of reperfusion differ when reperfusion is initiated by either thrombolysis or PTCA.

摘要

急性心肌梗死溶栓治疗后早期非侵入性再灌注检测,可能有助于及时发现溶栓未成功情况,以便进行补救性经皮腔内冠状动脉成形术(PTCA)。有人提出,重复检测肌红蛋白或肌酸激酶(CK)的MM同工酶可实现再灌注的早期检测。20例接受静脉溶栓治疗的急性心肌梗死患者,在溶栓开始后每30分钟进行一次肌红蛋白、MM3和MM1 CK同工酶的系列测定。90分钟时进行冠状动脉造影,据此将患者分为有再灌注组(A组)和无再灌注组(B组)。第三组7例患者(C组)未先行溶栓而直接接受PTCA。所有组中,肌红蛋白、MM3同工酶百分比及MM3/MM1比值均升高。B组这些升高平均出现得更陡更快,但该组数值离散度大,导致与A组有广泛重叠。回顾性分析表明,60分钟后MM3/MM1比值升高>0.35对再灌注具有高度特异性(敏感性60%,特异性100%)。C组中,PTCA总是导致30分钟内所测所有生化参数急剧升高。因此,大分子标志物可用于早期、非侵入性且特异性高的再灌注检测。这有助于减少为选择补救性PTCA候选者而进行急诊血管造影的需求。此外,溶栓或PTCA启动再灌注时,再灌注生化标志物的模式有所不同。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验